estrone has been researched along with Cardiac Hypertrophy in 1 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasumi, Y | 1 |
| Baba, M | 1 |
| Hasumi, H | 1 |
| Huang, Y | 1 |
| Lang, M | 1 |
| Reindorf, R | 1 |
| Oh, HB | 1 |
| Sciarretta, S | 1 |
| Nagashima, K | 1 |
| Haines, DC | 1 |
| Schneider, MD | 1 |
| Adelstein, RS | 1 |
| Schmidt, LS | 1 |
| Sadoshima, J | 1 |
| Marston Linehan, W | 1 |
1 other study available for estrone and Cardiac Hypertrophy
| Article | Year |
|---|---|
Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cell Line; Disease Mod | 2014 |